NEW YORK, July 26 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
This study encompasses feedback provided by U.S. diabetes patients on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight into current and future trends. Data was presented for the general objective point questions as well as analysis by disease subtype where applicable. Patient feedback about awareness, usage, and desired changes was obtained for Exubera and Byetta. For device driven delivery, autoinjector technology usage and willingness for adoption is assessed by patients, as well as other vital feedback on the role the device plays in the overall drug product. The corresponding physician deliverable is titled: 2008 U.S. Diabetes Drug Delivery - Physician Perspective (N7A6).
1 2008 U.S. DIABETES DRUG DELIVERY - PATIENT PERSPECTIVE